Suppr超能文献

药剂师需要了解的科学出版伦理知识。

What pharmacy practitioners need to know about ethics in scientific publishing.

作者信息

Zunic Lejla, Masic Izet

机构信息

Discipline of Pharmacology, Faculty of Health Sciences, University of Zenica, Zenica, Bosnia and Herzegovina.

Department of Family Medicine, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

出版信息

J Res Pharm Pract. 2014 Oct;3(4):112-6. doi: 10.4103/2279-042X.145356.

Abstract

Pharmacy practice is an ever-changing science and profession. We are witnessing many advancement of pharmacy technology, drug-related information and applied clinical pharmacy literature, which influence our every day's life. Thus, new knowledge generated by research and clinical experience widen the knowledge; change the understanding of drugs and their application in therapeutics and every days life. Thus, policy makers, pharmacists, clinicians and researchers must evaluate and use the information existing in the literature to implement in their healthcare delivery. This paper is prepared for pharmacy researchers and pharmacy students and analyzes the major principles of ethical conduct in general science and also closely related topics on ghost authorship, conflict of interest, assigning co-authorship, redundant/repetitive and duplicate publication. Furthermore, the paper provides an insight into fabrication and falsification of data, as the most common form of scientific fraud. Scientific misconduct goes against everything that normal scientific method wants to reach for and pharmacy practitioners as one the first line available health care professionals all round the world should be enough aware of its importance and details when they want to evaluate the medical and pharmaceutical literature and deliver unbiased and ethically published knowledge of drugs both for the research or during consultations for patients care.

摘要

药学实践是一门不断变化的科学与专业。我们见证了药学技术、药物相关信息以及应用临床药学文献的诸多进步,这些都影响着我们的日常生活。因此,研究和临床经验产生的新知识拓宽了知识面;改变了对药物及其在治疗和日常生活中应用的理解。所以,政策制定者、药剂师、临床医生和研究人员必须评估并运用文献中存在的信息,以在其医疗服务中加以实施。本文是为药学研究人员和药学专业学生撰写的,分析了一般科学中道德行为的主要原则,以及与代笔、利益冲突、共同作者署名、冗余/重复和重复发表等密切相关的主题。此外,本文还深入探讨了数据造假和伪造,这是科学欺诈最常见的形式。科学不端行为违背了正常科学方法所追求的一切,而作为全球一线医疗保健专业人员之一的药学从业者,在评估医学和药学文献以及提供公正且符合伦理规范发表的药物知识用于研究或患者护理咨询时,应该充分意识到其重要性和细节。

相似文献

5
Publication ethics and the ghost management of medical publication.出版伦理与医学出版的幽灵管理。
Bioethics. 2010 Jul;24(6):273-83. doi: 10.1111/j.1467-8519.2008.01702.x. Epub 2009 Feb 16.
6
Ethics and scientific publication.伦理与科学出版。
Adv Physiol Educ. 2005 Jun;29(2):59-74. doi: 10.1152/advan.00056.2004.
7
Ethical dilemmas in journal publication.期刊发表中的伦理困境。
Clin Dermatol. 2012 Mar-Apr;30(2):231-6. doi: 10.1016/j.clindermatol.2011.06.013.
9
Pitfalls and Misconducts in Medical Writing.医学写作中的陷阱与不当行为。
Int J Low Extrem Wounds. 2019 Dec;18(4):350-353. doi: 10.1177/1534734619870083. Epub 2019 Aug 29.
10
Misconduct by researchers and authors.研究人员和作者的不当行为。
Gac Sanit. 2007 Nov-Dec;21(6):492-9. doi: 10.1157/13112245.

本文引用的文献

3
Condemnation to plagiarism.谴责抄袭行为。
Rev Bras Cir Cardiovasc. 2014 Apr-Jun;29(2):I-II. doi: 10.5935/1678-9741.20140089.
4
Publication ethics.
Med Leg J. 2014 Dec;82(4):155-8. doi: 10.1177/0025817214526524. Epub 2014 Jun 27.
5
On the authorship criteria.关于作者身份标准。
Dent Res J (Isfahan). 2014 Mar;11(2):288.
7
Conflict of interest disclosures.
JAMA Intern Med. 2014 May;174(5):823. doi: 10.1001/jamainternmed.2014.758.
8
Publish or perish, publish and perish.不发表就灭亡,发表了也灭亡。
J Adhes Dent. 2014 Apr;16(2):103. doi: 10.3290/j.jad.a31870.
10
Data fabrication and falsification and empiricist philosophy of science.数据造假与科学的经验主义哲学。
Sci Eng Ethics. 2014 Jun;20(2):423-31. doi: 10.1007/s11948-013-9466-z. Epub 2013 Aug 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验